An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers
Kate Godfrey, Brandon Weiss, Joseph Peill, Taylor Lyons, Xiangan Zhang, Meg J. Spriggs, Robin Carhart-Harris, David Erritzøe
Neuroscience Applied December 2, 2024 DOI: 10.1016/j.nsa.2024.104092 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Within-subjects fixed-order design trial Peer reviewed |
|---|---|
| Population | Psychedelic-naïve healthy volunteers |
| Intervention | Psilocybin |
| Dose | 25 mg |
| Duration | One-month follow-up |
| Keywords | Personality Clinical psychology |
| Citations | 5 |
| Key findings | Significant reductions in neuroticism one month after 25 mg psilocybin administration, moderated by subjective meaningfulness and dread of ego dissolution. |
Abstract
This study investigated the effects of a single high-dose of psilocybin on personality traits in psychedelic-naïve healthy volunteers. These data originate from a larger within-subjects fixed-order design trial, where a single high dose of psilocybin (25 mg) was administered in a psychologically supportive setting and was compared against a (one-month) prior, 1 mg 'placebo' dose. Personality shifts were assessed by the Big Five Inventory and the Big Five Aspect Scale, while the Altered States of Consciousness questionnaire (5D-ASC) and the Psychological Insight Scale gauged the acute psychological effects of the substance. Electroencephalography provided neurophysiological insights, specifically examining alpha power and Lempel-Ziv complexity (LZc). Results indicated significant reductions in neuroticism one month after 25 mg psilocybin administration, a finding consistent with prior studies. Reductions in neuroticism were moderated by the subjective meaningfulness of the psychedelic experience, as well as by the dread of ego dissolution subscale of the 5D-ASC, suggesting a relationship between acute drug effects and enduring personality alterations. Thus, this study substantiates the role of acute psychedelic states in catalysing lasting personality transformations in a generally beneficial direction, with broader implications for therapeutic applications and understanding of personality dynamics.
Citations in the library
Cited by 6
- Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: a prospective survey study Journal of Affective Disorders Reports July 1, 2026
- EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes bioRxiv (Cold Spring Harbor Laboratory) June 12, 2026
- Classic psychedelics and personality: An updated systematic review. Journal of Psychopharmacology May 31, 2026
- Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review Pharmaceutical Science December 9, 2025
- Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review Frontiers in Psychiatry September 15, 2026
and 1 more in the library
Cites 60
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness Journal of Psychopharmacology September 28, 2011
and 55 more in the library